Features of post-tuberculosis bronchiectasis: Tunisian comparative study

H. Mrassi (Tunis, Tunisia), I. Bachouch (Tunis, Tunisia), N. Khezami (Tunis, Tunisia), N. Belloumi (Tunis, Tunisia), F. Chermiti (Tunis, Tunisia), S. Fenniche (Tunis, Tunisia)

Source: Virtual Congress 2021 – Bronchiectasis
Session: Bronchiectasis
Session type: E-poster
Number: 2065

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Mrassi (Tunis, Tunisia), I. Bachouch (Tunis, Tunisia), N. Khezami (Tunis, Tunisia), N. Belloumi (Tunis, Tunisia), F. Chermiti (Tunis, Tunisia), S. Fenniche (Tunis, Tunisia). Features of post-tuberculosis bronchiectasis: Tunisian comparative study. 2065

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Severe sarcoidosis: a comparative study
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017


Characterisation of eosinophilic bronchiectasis: A European multicohort study
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021



Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Bacterial colonisation in children with non-cystic fibrosis bronchiectasis: a retrospective longitudinal study
Source: International Congress 2017 – Paediatric bronchology in clinical practice
Year: 2017


Predictors of exacerbations in hospitalised patients with bronchiectasis: A retrospective study in an Asian population
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


Patterns of pulmonary hypertension in Egyptian patients with COPD: A retrospective analysis
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study
Source: Eur Respir J, 52 (1) 1800766; 10.1183/13993003.00766-2018
Year: 2018



Pulmonary rehabilitation in bronchiectasis: a propensity-matched study
Source: Eur Respir J, 53 (1) 1801264; 10.1183/13993003.01264-2018
Year: 2019



Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study
Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019
Year: 2019



Etiology and clinical characteristics of bronchiectasis in Taiwan: a multi-center cohort study
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019


Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020

Clinical cases: COPD and bronchiectasis
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

Prevalence of idiopathic pulmonary fibrosis in Japan and the US: a claims-based retrospective study
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Comorbidities in sarcoidosis: a retrospective Italian study
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020


Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study.
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers
Year: 2018


Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016

Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016


Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Tsukamurella species isolation in bronchiectasis and chronic obstructive pulmonary disease patients: A retrospective case series
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018